Background.
Introduction
In the United States, the prevalence of stage 3 and 4 chronic kidney disease after the age of 70 increased from 27.8% between 1988 and 1994 to 37.8% in the period 1999-2004 [1] . With the tremendous effort made to prevent renal disease progression, one may expect the stabilization of the end-stage renal disease incidence. However, the total number of elderly patients starting dialysis will go up because of increasing life expectancy [2, 3] . Data from the US Renal Data System (USRDS) indicate that the number of patients older than 80 starting dialysis increased from 7054 in 1996 to 13 577 in 2003 [4] . In Canada, the majority of patients starting dialysis are older than 65 years [3] . In France, in 2006, the median age at dialysis initiation was 70 years, and 36% of the patients on dialysis were older than 75 years [5] . In developed countries, patient age is no longer considered a limitation for renal replacement therapy. Therefore, nephrologists have to treat an increasing number of elderly patients with end-stage renal disease.
'Conservative therapy' can be considered as an option for elderly patients with end-stage renal disease [6, 7] . In one recent study, determinants for not initiating dialysis in elderly patients were late referral, social isolation and functional dependence [8] . Theoretically, a free choice of the dialysis modality should be offered to elderly patients who need to be treated by dialysis [9] . Nevertheless, older age is frequently associated with contraindication to peritoneal dialysis (PD) [10] . The under-utilization of PD in elderly patients is linked with the inability of the patient to perform PD exchanges because of functional impairment or cognitive dysfunction. Assisted PD is fully covered by the national health care insurance in France. This possibility, which should be considered as a tremendous advantage, allows French nephrologists to treat elderly patients by PD [11] . There is clearly no consensus concerning the optimal mode of renal replacement therapy for elderly patients. Little is known about the result of PD in elderly patients, especially in the context of assisted PD. The aim of this study is to provide information regarding the outcome of elderly patients treated with PD in a country where inability to be autonomous is not a contraindication for PD. 
Subjects and methods

Study population
This was a retrospective study based on the data extracted from the RDPLF (French Language Peritoneal Dialysis Registry). The RDPLF was set up in 1986. In France, 82% of all PD patients are registered in the RDPLF. There are currently 25 000 patients recorded since 1986 in the Registry, among them 21 000 from France, 1000 from French territories and 3000 from French-speaking countries. Participating centres provide updated information regarding their patients every 3 months. Details about the registry management have been published recently [12] . It has been shown that the French dialysis registry (REIN) and the RDPLF had a good global concordance [13] . We identified all patients included in the RDPLF database who started PD in France (excluding the French territories) between 1 January 2000 and 31 December 2005 and who were at least 75 years old at the start of PD. Patients were excluded if they had previously been treated by PD, haemodialysis (HD) for >90 days, or renal transplantation. The follow-up was until 31 December 2007 when patients still on PD were administratively censored. Patients were included since 2000 instead of 1986 (date of the RDPLF set-up) in order to have a recent date more representative of current practice and dialysis methods that may have differed from the early clinical practices.
Definition of outcome events
We examined patient survival (death as the outcome event), death-censored technique survival (permanent transfer to HD as the outcome event), technique survival (permanent transfer to HD or death were the outcome events) and peritonitis-free survival (first episode of peritonitis was the outcome event). In each analysis, patients were censored on all other reasons for stopping PD.
Definition of explanatory variables
We extracted patients' sex, age upon starting PD, type of PD and method of assistance at Day 90 after starting PD and with underlying nephropathy. Using an intent to treat approach, the type of PD and the method of assistance were defined at Day 90 irrespective of patients' later changes. Underlying nephropathies were recoded in six categories. As comorbidity measures, we extracted the Charlson comorbidity index (CCI) at the start of PD. Age was included in the Charlson score calculation. In an attempt to evaluate the role of the comorbidities independently of the patients' age, we calculated a modified CCI by subtracting the age subscore. We also extracted diabetes mellitus status at the last recorded follow-up visit. This definition aimed to reduce misclassification of diabetic patients undiagnosed at the start of PD since incident diabetes was considered unlikely in this age group. To examine the role of centre experience on the patients' outcome, we calculated the mean of the number of all adult (not only elderly) patients active on PD per day for each centre from 1 January 2000 to 31 December 2007. This centre-size variable was then arbitrarily transformed into three classes.
Statistical analysis
Owing to possible non-linearity and to allow easier clinical interpretation, age was transformed into a categorical variable of 5-year groups and the CCI and the modified CCI were transformed into categorical variables of three classes. Continuous variables were described by means and standard deviations; categorical variables were described as frequencies and percentages. Unadjusted survival analyses were performed using the KaplanMeier method to draw curves for each of the four outcome events of interest (patient survival, death-censored technique survival, joint-outcome technique survival and peritonitis-free survival) and to calculate median survival by each explanatory variable. The unadjusted hazard ratio (HR) and 95% confidence intervals were calculated by bivariate Cox regression and differences tested by the log-rank test. Adjusted survival analyses were performed with multivariate Cox regression models. We first estimated models that examined all individual-level explanatory variables (i.e. all except centre size) by including all variables with P < 0.20 in the unadjusted analyses in the starting model. Since age and diabetes are part of the CCI calculation, separate models were estimated for age with the modified CCI and age with as indicated. Causal nephropathy was not included in models with diabetes since estimating the effect of diabetic nephropathy in non-diabetic patients is meaningless. For model selection, we used stepwise elimination of variables based on statistical significance and, as a consistency check, also the Akaike information criterion (AIC). The final models were adjusted for the centre as a random effect. We evaluated the centre size using a second set of models. The unadjusted effect was estimated using a bivariate Cox regression that also included the centre as a random effect to ensure correct estimation of the centre size standard error. We then estimated the adjusted effect of the centre size in the four survival analyses of interest by adding the other explanatory variables to this model. Statistical significance testing in models including random effects was based on marginal log-likelihood differences [14] . No interaction terms considered relevant on a priori grounds were significant in any model. The proportional hazard assumption was tested visually by scaled Schoenfeld residual plots and outliers examined by dfbeta plots [15] . The method of assistance was the only variable not meeting the proportional hazards assumption for death-censored technique survival but did not qualify for the multivariate models (P > 0.20 in univariate analysis). Competitive risks, although present, were not taken into account to allow comparison with the PD literature that does not address them in analyses. Statistical significance was accepted for P ≤ 0.05. All analyses were done with R 2.7.2 (R Foundation for Statistical Computing, 2008).
Results
Patient characteristics
Among 6724 patients starting PD during the study period, 1865 patients met the inclusion criteria. Of these 1865 patients, 252 were excluded because of missing data; 1613 patients were included in the analysis. There was no significant difference between the group of patients excluded because of missing data and the group of patients included for the analysis regarding the mean age at dialysis initiation, the mean modified CCI and the type of PD modality and assistance. These 1613 patients were treated in 115 dialysis centres. These centres were classified in three groups according to the mean number of all adult patients active on PD per day [<20 (68/115 centres); 21-30 (26/115 centres) and >30 (21/115 centres)]. There were 614/1631 patients treated in the group of centres with <30 active patients per day, 481/1613 patients in the group of centres with 21-30 active patients per day and 518/1613 patients in centres with >30 active patients per day. The mean age at dialysis initiation was 81.9 ± 4.5 years, and 984 of the 1631 patients were older than 79 years; the sex ratio (M/F) was 884/729. In the study population, 545 patients (33.8%) had a CCI >9, and 357 patients (22.1%) had a modified CCI value of >5. Detailed information about baseline patient characteristics is provided in Table 1 . Continuous ambulatory peritoneal dialysis (CAPD) was the PD modality used for 1435 patients (89%). Of the 1613 patients, 1319 (81.8%) needed assistance to perform their PD exchanges: 87 (5.4%) were helped by a family member and 1232 (76.4%) were assisted by a nurse working in the private sector. The characteristics of assisted PD patients are provided in Table 2 . Compared with autonomous elderly patients, assisted PD patients were older and had a greater modified CCI.
Patient survival on PD
The median patient survival was 27.1 months; the median patient survival for age groups 75-79 years, 80-84 years, 85-89 years and >90 years were, respectively, 31, 26.9, 21.8 and 14.2 months. On univariate analysis, age, diabetes mellitus, CCI (Figure 1 ), modified CCI, PD modality, method of assistance ( Figure 2 ) and underlying nephropathy were associated with patient survival (Table 3 ). In the multivariate analysis (Table 3) , survival was affected by sex, age, modified CCI, method of assistance and underlying nephropathy in model 1 and by sex, age, PD modality, method of assistance and diabetes mellitus in model 2.
When compared with automated peritoneal dialysis (APD) 
Fig. 2.
Kaplan-Meier curves of patient survival according to the modality of assistance for elderly patients on peritoneal dialysis (log rank test: P < 0.001 for the autonomous versus the family-assisted group and for the autonomous versus the nurse-assisted group, P < 0.001).
patients, CAPD patients were older and had a greater modified CCI (Table 4) . In addition, patients on CAPD were more frequently assisted by a nurse than patients on APD (1148/1435 versus 84/178, P < 0.01). Among 849 deaths, 39 were due to peritonitis. Malnutrition was reported as a cause of death in 64 patients.
Death-censored technique survival
On univariate analysis, patient age, sex, diabetes, method of assistance and underlying nephropathy had no effect on technique survival (Table 5 ). CCI and modified CCI 258 C. Castrale et al. 
Survival free of peritonitis
The median survival free of peritonitis was 32.1 months. The median survival free of peritonitis for age groups 75-79 years, 80-84 years, 85-89 years and >90 years were, respectively, 29.4, 34.1, 37.7 and 30.4 months. On univariate analysis, age, sex, diabetes, CCI, modified CCI, PD modality, method of assistance and underlying nephropathy were not associated with the peritonitis risk (Table 6 ). Causative micro-organisms are listed in Table 7 .
Effect of the centre size
On the unadjusted analyses, the centre size was associated with a longer death-censored technique survival, whereas there was neither an association with the risk of death nor with the risk of peritonitis. After adjustment for age, sex, modified CCI, PD modality, method of assistance and underlying nephropathy (model 1) or after adjustment for age, sex, diabetes, PD modality and method of assistance (model 2), there was still an association between the centre size and technique survival (Table 8) .
Discussion
In France, elderly patients have been treated by assisted PD for more than a decade [16] . Data from the French Registry REIN show that incident end-stage renal disease patients older than 75 are more likely to be treated by PD than other patients [17] . In the meantime, one recent French study from the same group has shown that unplanned HD and PD were associated with an increased risk of death compared to planned HD in patients older than 75 years [18] . However, it is important to note that PD start could be planned or unplanned, which may have an impact on the patients' outcome. One may hypothesize that the clinical experience of PD in the elderly varied significantly between the different centres. Therefore, a centre effect may play a role in the elderly patients' outcome on PD [19, 20] . With the opportunity to be treated at home with nurse assistance, PD is probably considered to be a dialysis modality associated with a better quality of life, either by the patients or by the nephrologists. Compared with non-end-stage renal disease patients, elderly patients on dialysis have a lower quality of life [21] . To our knowledge, there are no data 260 C. Castrale et al. available regarding the quality of life of elderly patients on assisted PD. Harris et al. found that quality of life of elderly patients on PD and HD in the North Thames Dialysis Study (NTDS) did not differ significantly between the two dialysis modalities [22] . The higher failure rate of fistulae creation, may also explain the fact that elderly patients are more frequently treated by PD when assisted PD is available [23] . Older patients on dialysis often have cardiovascular comorbidities [24] . Cardiac diseases in patients on HD can cause hypotension and arrhythmias, which in turn may influence the choice of the dialysis modality [17] . Economic considerations may also influence dialysis modality selection for the elderly [25] . Benain et al. showed that PD saves costs for the French Health Care Insurance, even with the additional cost of assisted PD [26] . In our study, 76.4% of elderly patients were treated by assisted PD. Surprisingly, one recent study from Hong Kong showed that a high percentage of patients older than 65 years treated by PD were able to be autonomous [27] . Of 31 non-institutionalized octogenarian patients on PD, only 2 were able to perform dialysis by themselves in two Canadian centre experiences [24] . This finding highlights the fact that assisted PD funding is clearly needed in order to increase the rate of PD utilization [28] [29] [30] [31] .
Only a few large-scale studies provide information regarding the survival of elderly patients on PD. In the NTDS, the 1-year survival rate was 69% [32] . The 2008 UK Renal Registry reported a median renal replacement therapy of 2.1 years [33] . The 2-year patient survival rate was 89% in patients older than 65 treated by PD in Hong Kong [27] . As expected, patient survival on PD was affected by the comorbidities assessed by the CCI. In addition, comorbidities, independently of the patient's age, were associated with the mortality risk on PD. These findings are consistent with the results of Vrtovsnik et al. and Couchoud et al. [17, 34] . Our report shows that patients assisted by a nurse had a greater mortality risk than other patients. This suggests that factors related to disabilities, which were not captured in our study, are predictors of survival [35, 17] . Our results show that PD is a suitable method for elderly patients with ESRD selected for renal replacement therapy in terms of survival.
In the study of Li et al., the 2-year technique survival was 84% [27] . In our study, comorbidities were associated with death censored technique survival, perhaps as a marker of medical decision to avoid patient transfer to HD when individual life expectancy was thought to be short. Because assisted PD is available in France, very frail elderly patients can be treated by PD. One can assume that these frail elderly patients are less likely to be transferred to HD than other patients. One can also hypothesize that frail elderly patients on dialysis are not treated with an integrative approach; this may explain the fact that elderly patient mortality is higher in PD compared to that in HD [36] . This could also reflect the patient's decision and perception of the dialysis modality switch. Patients' preferences concerning the dialysis modality could have more importance than the survival on dialysis [37] . Because of the lack of data regarding PD in the elderly, there is no study to date to confirm this hypothesis. Interestingly, the centre size was associated with technique failure. In the study of Schaubel et al., there was a significant association between centre experience and both mortality and technique survival on PD [18] . It is very important to notice that loss of assistance was not a frequent cause of technique failure in our study.
Even though elderly patients could be more exposed to peritonitis because of functional impairment, immunodeficiency and diverticulitis, our results show that the median survival free of peritonitis was better than the ISPD Guidelines target [38] . Our findings agree with those of previous studies [16, 24, 27, 39] . CCI did not affect the peritonitis risk in our study. Although no assisted PD patients were included in their study, our results are consistent with the finding of Nessim et al. [40] . They found that patients older than 70 were not more exposed to peritonitis than younger patients. However, these patients were probably selected according to their capability of performing their own PD exchanges or being assisted by a family member. Verger et al. showed that nurse-assisted APD patients had a higher risk of peritonitis than family-assisted APD patients [41] . Nurse assistance was not identified as a peritonitis risk factor in our study. However, our results show that the vast majority of elderly patients on PD in France are treated by Peritoneal dialysis in elderly patients 261 CAPD. Most of the time, assisted CAPD patients are treated with a non-disconnectable UV Flash device in order to save time for the nurse at the patient's home [42] . Surprisingly, gram-negative peritonitis was not over-represented in our study.
In view of our data, one should consider that PD is a suitable method to treat elderly patients. It is nevertheless obvious that elderly patients require assistance when treated by PD. Medical decision about transferring a patient to HD may be influenced by the comorbidity burden. Further studies are needed to compare quality of life of elderly patients on in-centre HD and on assisted PD.
Introduction
Peritoneal dialysis (PD) is a well-known and widely used renal replacement therapy, but it is crucial to assess the adequacy of PD because of its influence on patient outcome [1, 2] .
In addition to evaluating water and sodium balance, this assessment involves calculating the weekly urea clearance normalized according to body water (Kt/V), and the weekly creatinine clearance (CrCL) normalized to a body surface area of 1.73 m 2 (CrCL/1.73). Although the NKF-K/DOQI Guidelines for Peritoneal Dialysis Adequacy 2001 recommend measuring the total solute clearance every 4 months [3] , the adequacy of dialysis in patients on PD is often assessed only twice a year because it can be rather tiresome. It involves collecting dialysate (sometimes more than 25 L) and urine simultaneously for 24 h, combining and weighing the two fluids and sending samples to the laboratory together with a blood sample, then interpreting the results and calculating the adequacy indexes.
As a result, the same dialysis prescription may be applied for at least 4-6 months, during which time there may be a decline in a patient's residual renal function, making their total solute clearance shift into a range that is no longer adequate.
It would be very useful to have simple, inexpensive tools requiring no fluid collection to enable adequacy of dialysis
